An expert answered CURE® readers’ questions on several aspects of a prostate cancer journey, including treatment options and ...

Feeling fatigued unmotivated or not like your usual self can sometimes be more than just stress For men these feelings might indicate lower testosterone levels-a common problem many encounter Testoste ...

BAYRY moves ahead with the submission of an application seeking approval of darolutamide in combination with androgen ...

The FDA received an application for Nubeqa as a potential treatment option with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer.

A supplemental new drug application seeking expanded indication for darolutamide combined with androgen deprivation therapy ...

Radiopharmaceuticals have been used to treat patients with prostate cancer for decades, but experts say there is more to learn about these agents.

German pharmaceutical company Bayer AG (BAYZF.PK, BAYRY.PK, BYR.L) announced Thursday the submission of a supplemental new drug ...

The following is a summary of “American Radium Society Appropriate Use Criteria for the Workup and Treatment of Local ...

Finnish drugmaker Orion wants to boost sales in the United States on the back of the success of its prostate cancer drug Nubeqa, which it is developing jointly with German partner Bayer, Orion's chief ...

The prostate is a small gland located in the male reproductive system that's essential for producing seminal fluid. When it's ...

DelveInsight's CDK 7 Inhibitors Market Insights report includes a comprehensive understanding of current treatment practices, ...

Diindolylmethane (DIM) is a compound that influences estrogen metabolism. There is growing interest in its role in hormonal ...